Blog

Research!America is dedicated to ensuring a strong public and private sector investment in research to improve health at a level warranted by scientific opportunity and supported by public opinion. Each blog post aims to inform readers about the health and economic benefits of research.  

Recent Blog Posts

Research!America today unveiled the Campaign for Cures 2016 election blog and an online interactive map . The interactive map features hundreds of quotes from candidates across the political spectrum related to public and private sector research and innovation. The blog, managed by former USA Today senior editor and health reporter Janice Lloyd, features election news, survey data, commentary and analysis of presidential and congressional races in key states on topics relevant to medical progress. The map and blog are the latest resources for voters as part of Campaign for Cures: Vote for Medical Progress , a national voter education initiative supported by Research!America and partner...
After 27 years in Old Town Alexandria, we are relocating to the Crystal City neighborhood of Arlington, VA -- right above the Metro and one stop from Reagan National Airport. Beginning June 27, Research!America's new address is: 241 18th Street South, Suite 501 Arlington, VA 22202 Our phone numbers remain the same. There may be an interruption in phone service during the move. We thank you for your understanding if there are any delays in returning phone calls or emails during June 24-27.
Dear Research Advocate: If you’ve read Ron Chernow’s “Hamilton,” you know that the partisan stand-off we are witnessing in the House, and more broadly across the nation, is not new. Chernow reminds us that political parties -- not originally foreseen by the Founding Fathers -- grew out of intense and often ugly disagreements between Alexander Hamilton and Thomas Jefferson during the second administration of George Washington. That insight doesn’t make this week’s turn of events less dramatic, but it does offer perspective. In the midst of the Democratic sit-in on preventing gun violence, the House adjourned earlier than expected and won’t resume business until July 5. Just before adjourning...
Dear Research Advocate: As we grieve the worst mass shooting in U.S. history, the spectre of more to come is deeply troubling. If there were ever a time for action by our elected officials, surely this is it. Yesterday, Senator Chris Murphy (D-CT) took to the Senate floor in a nearly 15 hour filibuster to demand action on gun reform, which ended in Republican leadership agreeing to a vote on two pieces of legislation related to gun sales. Senator Murphy was joined by many of his colleagues, including Senator Richard Durbin (D-IL), who said that the American Medical Association’s declaration of gun violence as a public health crisis is “historic,” entering their press release into the record...
As the population ages, is it possible to prevent, intercept and delay the onset of disease to live not only longer but expand the healthy period of life? Academic and industry experts discussed the concept of immorbidity - a perspective on medicine in which the priority shifts from treating or curing diseases like cancer and Alzheimer's to preventing, intercepting and halting the progression of disease -- at a session titled "Lifespan or Healthspan: Is it Time for a Paradigm Shift?" at the BIO International Convention on Wednesday, June 8. Dr. Keith Yamamoto, executive vice dean of the School of Medicine at the University of California, San Francisco and Dr. William N. Hait, global head of...
Dear Research Advocate: This has been an important week for research, innovation and the power of advocacy. The Senate Appropriations Committee passed the Labor-H bill, which funds NIH, CDC and AHRQ, among other programs. The bill includes a well-justified, but nonetheless remarkable, $2 billion increase for NIH in FY17. However, CDC and AHRQ both receive cuts in the bill ($118 million and $10 million, respectively). While we applaud Chairman Blunt (R-MO), Ranking Member Murray (D-WA) and the Committee as a whole for their extraordinary determination to regrow the NIH budget, underinvesting in CDC and AHRQ is a costly mistake. Read our statement on the bill. It is important to note that...
How to shape and communicate the value of medical innovation is top of mind for research stakeholders as they balance the cost of innovation with meeting the needs of patients. Experts representing industry and payers discussed the challenges of defining innovation in the policy, market and political environments during a session at the BIO International Convention on Tuesday, June 7. Josh Ofman, senior vice president at Amgen noted that industry needs to be more proactive in communicating the value proposition of innovation: "We need a holistic picture of value from a societal perspective, patient perspective and payer perspective." "Groups need to look at models that work" in assessing...
Actor Will Smith joined Dr. Bennet Omalu and BIO president Jim Greenwood for a keynote address today at the BIO International Convention examining the science that led to the discovery of chronic traumatic encephalopathy (CTE) in football players and other athletes. Smith portrayed Omalu in the movie "Concussion" which focused on Omalu's discovery of CTE in former football players and his efforts to convince the National Football League (NFL) of the relationship between concussions and repetitive brain trauma with CTE. Omalu said he examined former Pittsburgh Steelers' football player Mike Webster's brain with his own money and brought it to his home which allowed him to own the...
Elected officials, business leaders, university presidents from across the state, leaders of biotech companies and nationally-ranked medical centers, and research scientists came together to discuss public-private partnerships and other initiatives that maximize the impact of medical research on the local and national economy, and benefit the health of citizens. Research!America and Northeast Ohio Medical University co-hosted the forum, “Medical Research: The Right Prescription for Economic Growth,” at the NEOMED Education and Wellness Center in Rootstown, Ohio on June 6. “Federal investment in R&D, especially basic research, is critical to success, and is a good thing for our economy...
Dear Research Advocate: The news from the CDC this week is concerning. For the first time in over a decade the overall, all-cause mortality rate for the U.S. is higher than in the preceding year. This unexpected news comes on the heels of last week’s announcement confirming the first U.S. case of an E. coli infection resistant to colistin, a last-resort antibiotic, reminding us of just how important it is to curtail and outpace antimicrobial resistance. And we have word of the second baby born in the U.S. with microcephaly due to Zika, as well as a new estimate that 300 pregnant women in the U.S. have the virus. On their own, each of these stories should serve as a wake-up call for...

Pages

America’s economic destiny lies in innovation, technology, science and research.
The Honorable John E. Porter